UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________
FORM
_________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
_______________________________
(Exact name of registrant as specified in its charter)
_______________________________
(State or Other Jurisdiction of Incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code:
_______________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company,indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 2.02. Results of Operations and Financial Condition.
On July 31, 2019, Willis Towers Watson Public Limited Company (“Willis Towers Watson”) issued a press release announcing its financial results for the period ended June 30, 2019. Willis Towers Watson also posted a slide presentation to its website, which it may refer to during its conference call to discuss the results.
A copy of Willis Towers Watson’s press release and slide presentation are attached hereto as exhibits to this Current Report on Form 8-K and are incorporated by reference herein. A reconciliation between certain non-GAAP financial measures and reported financial results is provided as an attachment to the press release.
Item 7.01 Regulation FD.
The slide presentation referred to in Item 2.02 above is attached hereto as Exhibit 99.2 and incorporated herein by reference.
The information contained in Item 2.02 and Item 7.01 of this Current Report on Form 8-K (including Exhibits 99.1 and 99.2) is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. Such information shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.
Item 9.01. Financial Statements and Exhibits
(d) | Exhibits |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
WILLIS TOWERS WATSON PUBLIC LIMITED COMPANY | ||
Date: July 31, 2019 | By: | /s/ Neil D. Falis |
Neil D. Falis | ||
Deputy Company Secretary | ||
EXHIBIT 99.1
Willis Towers Watson Reports Strong Second Quarter 2019 Earnings
ARLINGTON, Va. and LONDON, July 31, 2019 (GLOBE NEWSWIRE) -- Willis Towers Watson (NASDAQ: WLTW) (the “Company”), a leading global advisory, broking and solutions company, today announced financial results for the second quarter ended June 30, 2019.
“We are pleased with our financial results for the second quarter and first half of fiscal 2019. For the second quarter, we delivered 6 percent organic revenue growth, and each of our business segments demonstrated healthy growth in revenue and operating income margin, contributing to a double-digit increase in adjusted operating income growth for the overall Company,” said John Haley, Willis Towers Watson’s chief executive officer. "We are also excited to announce the successful completion of the TRANZACT acquisition, which will rapidly accelerate Willis Towers Watson’s direct-to-consumer U.S. healthcare strategy and significantly strengthen Willis Towers Watson’s growth profile in the healthcare space. This acquisition coupled with our highly differentiated capabilities and disciplined management of the business, leaves us confident in our ability to continue to drive sustainable, profitable growth and deliver value for our clients and shareholders.”
Company Highlights
Revenue was $2.05 billion for the second quarter of 2019, an increase of 3% (6% increase constant currency and organic) as compared to $1.99 billion for the same period in the prior year.
For the first half of 2019, revenue was $4.36 billion, an increase of 2% (5% increase in constant currency and organic) as compared to $4.28 billion for the same period in the prior year.
Net income attributable to Willis Towers Watson for the second quarter of 2019 was $138 million, an increase of 138% from $58 million for the prior-year second quarter. For the quarter, diluted earnings per share were $1.06 and adjusted diluted earnings per share were $1.78. The U.S. GAAP tax rate for the quarter was 19.7%, and the adjusted income tax rate for the quarter used in calculating adjusted diluted earnings per share was 21.4%.
For the first half of 2019, net income attributable to Willis Towers Watson was $425 million, a 56% increase from $273 million for the same period in the prior year. Diluted earnings per share for the first half of 2019 were $3.26, and adjusted diluted earnings per share were $4.76. Net income attributable to Willis Towers Watson and diluted earnings per share for the first half of 2019 included pre-tax $6 million of transaction and integration expenses related to the TRANZACT acquisition. For the first half of 2019, the U.S. GAAP tax rate was 19.1%, and the adjusted income tax rate used in calculating adjusted diluted earnings per share was 20.6%.
Net income for the second quarter of 2019 was $149 million, or 7.3% of revenue, an increase from net income of $65 million, or 3.3% of revenue for the prior-year second quarter. Adjusted EBITDA for the second quarter of 2019 was $425 million, or 20.8% of revenue, an increase from adjusted EBITDA of $392 million, or 19.7% of revenue for the prior-year second quarter.
For the first half of 2019, net income was $442 million, or 10.1% of revenue, an increase from net income of $286 million, or 6.7% of revenue for the same period in the prior year. Adjusted EBITDA for the first half of 2019 was $1 billion, or 23.5% of revenue, an increase from adjusted EBITDA of $949 million, or 22.2% of revenue.
_____________________________________
1 The revenue amounts included in this release are presented on a U.S. GAAP basis except where stated otherwise. The segment discussion is on an organic basis.
Operating income margin improved by 540 basis points compared to the second quarter of the prior year. Adjusted operating income margin improved by 160 basis points to 14.6% from 13.0% in the prior-year second quarter. Margin improvement was driven by enhanced margin performance across all segments.
For the first half of 2019, operating income margin improved by 480 basis points compared to the same period in the prior year. Adjusted operating income margin improved by 170 basis points to 18.1% from 16.4% for the first half of 2019.
Cash flows from operating activities for the six months ended June 30, 2019 was $303 million compared to $395 million for the prior-year first half. Free cash flow for the six months ended June 30, 2019 and 2018 was $183 million and $254 million, respectively. During the six months ended June 30, 2019, the Company repurchased approximately $51 million of Willis Towers Watson stock.
Segment Highlights
Human Capital & Benefits
The Human Capital & Benefits (HCB) segment had revenue of $797 million, an increase of 2% (5%increase constant currency and 5% increase organic) from $780 million in the prior-year second quarter. On an organic basis, Health and Benefits delivered significant revenue growth, driven by increased consulting and brokerage services, growth in specialty products, and expansion of our client portfolio for both local and global appointments. Health and Benefits’ revenue growth was aided by a lower revenue comparable in the prior-year second quarter. The prior year results reflect the impact of adopting the new revenue standard (ASC 606), which resulted in certain revenue not being recognized. Our Talent and Rewards business revenue grew primarily as a result of increased product revenue and advisory work in Great Britain and North America. Technology and Administration Solutions revenue also increased in connection with greater project demand primarily in Western Europe. Retirement revenue declined slightly compared to the prior-year second quarter primarily as a result of non-recurring project work in the comparable period. The HCB segment had an operating margin of 21% as compared to 19% for the prior-year second quarter.
Corporate Risk & Broking
The Corporate Risk & Broking (CRB) segment had revenue of $690 million, an increase of 2% (5%increase constant currency and 5% increase organic) from $674 million in the prior-year second quarter. The segment had solid growth across all geographies. On an organic basis, North America continued to lead the segment with new business generation. International, Western Europe and Great Britain also contributed meaningful growth for the segment, related to strong management of the renewal book portfolio alongside new business wins. The CRB segment had an operating margin of 15%, as compared to 14% for the prior-year second quarter.
Investment, Risk & Reinsurance
The Investment, Risk & Reinsurance (IRR) segment had revenue of $409 million, an increase of 6% (9% increase constant currency and 8% increase organic) from $385 million in the prior-year second quarter. On an organic basis, all lines of business contributed to the segment’s strong performance. Reinsurance and Underwriting and Capital Management growth was driven by net new business growth and favorable renewal factors while Insurance Consulting and Technology revenue grew from strong technology sales. Max Matthiessen revenue increased as a result of overall growth in net commissions. Both the Wholesale and Investment businesses returned to revenue growth in the second quarter as a result of increased net new business and improved asset-based fees. The IRR segment had an operating margin of 27% as compared to 23% for the prior-year second quarter.
Benefits Delivery & Administration
The Benefits Delivery & Administration (BDA) segment had revenue of $126 million, an increase of 6% ( 6%increase constant currency and 6% increase organic) from $119 million in the prior-year second quarter. BDA’s growth was primarily led by the continued expansion of its client base and increased demand for project work in the mid-market and large-market spaces. The BDA segment had an operating margin of negative 20%, as compared to negative 26% for the prior-year second quarter.
2019 Guidance Update
Willis Towers Watson is raising its 2019 earnings guidance primarily to reflect the acquisition of TRANZACT. For 2019, with TRANZACT, the Company expects constant currency revenue growth of 7% to 8%. On an organic constant currency growth basis the Company expects 4% to 5% revenue growth. The Company is raising its Adjusted Diluted Earnings Per Share guidance to a new range of $10.75 to $11.10 for the full year 2019, versus its previous guidance of $10.60 to $10.85. See supplemental slides for additional details on guidance.
Conference Call
The Company will host a live webcast and conference call to discuss the financial results for the second quarter. It will be held on Wednesday, July 31, 2019, beginning at 9:00 a.m. Eastern Time, and can be accessed via the Internet at www.willistowerswatson.com. The replay of the call will be available shortly after the live call for a period of three months. A telephonic replay of the call will also be available for 24 hours at 404-537-3406, conference ID 1779096.
About Willis Towers Watson
Willis Towers Watson (NASDAQ: WLTW) is a leading global advisory, broking and solutions company that helps clients around the world turn risk into a path for growth. With roots dating to 1828, Willis Towers Watson has more than 45,000 employees serving more than 140 countries. We design and deliver solutions that manage risk, optimize benefits, cultivate talent, and expand the power of capital to protect and strengthen institutions and individuals. Our unique perspective allows us to see the critical intersections between talent, assets and ideas — the dynamic formula that drives business performance. Together, we unlock potential. Learn more at willistowerswatson.com.
Select Questions and Answers
Q1: What were the financial terms of the TRANZACT deal?
As part of the TRANZACT acquisition closing, we amended the earn-out provision portion of the acquisition agreement to lower the potential earn-out from $200 million to approximately $17 million, agreeing to pay an additional $117.5 million in up-front purchase price as part of the closing on July 30, 2019. As a result, the purchase price payable by the Company at closing was increased from $1.2 billion to $1.3175 billion, subject to certain adjustments, and the potential earn-out payment due upon the achievement of certain financial targets in 2019 and 2020 was decreased from $200 million to approximately $17 million based upon the achievement of certain 2020 financial targets, payable in cash. This amendment allows the Company to reduce its earn-out exposure and lower the potential overall consideration paid for TRANZACT by approximately $65.5 million if the full earn-out objectives were to be achieved.
Q2: What was the impact of foreign currency movements for the second quarter and year to date?
For the quarter ended June 30, 2019, currency translation caused a decrease in our consolidated revenue of $51 million, and was immaterial to adjusted diluted earnings per share. For the six months ended June 30, 2019, currency translation caused a decrease in our consolidated revenue of $135 million, resulting in a decrease of $0.12 to adjusted diluted earnings per share.
Q3: What was the impact of the Company’s adoption of the new lease accounting standard (ASC 842, Leases)?
ASC 842 became effective, and was adopted by the Company, on January 1, 2019. The adoption of this new guidance had no material impact to the amounts and classifications of the balances within our condensed consolidated statements of income. On our condensed consolidated balance sheets we recognized an additional $1.2 billion of lease liabilities; $1.0 billion of right-of-use assets; additional deferred tax assets of $252 million and deferred tax liabilities of $252 million on the gross lease-related liabilities and gross right-of-use assets, respectively. See Note 12 – Leases, within the Company’s Form 10-Q for the quarter ended June 30, 2019 for a full description of the impact on the Company from adoption, adoption elections made and the newly-required disclosures.
Q4: What is your view of insurance pricing in the market?
We have seen a modest but definite improvement with pricing in the market. For a comprehensive look at overall market pricing in the primary and reinsurance markets, please view the “Insurance Marketplace Realities: Spring 2019 Update”, and the “Willis Re: 1st View” which can both be found on the Willis Towers Watson website. Please note that such reports are current as of the date of their publication.
Willis Towers Watson Non-GAAP Measures
In order to assist readers of our consolidated financial statements in understanding the core operating results that Willis Towers Watson’s management uses to evaluate the business and for financial planning, we present the following non-GAAP measures: (1) Constant Currency Change, (2) Organic Change, (3) Adjusted Operating Income, (4) Adjusted EBITDA, (5) Adjusted Net Income, (6) Adjusted Diluted Earnings Per Share, (7) Adjusted Income Before Taxes, (8) Adjusted Income Taxes/Tax Rate and (9) Free Cash Flow.
The Company believes that these measures are relevant and provide useful information widely used by analysts, investors and other interested parties in our industry to provide a baseline for evaluating and comparing our operating performance, and in the case of free cash flow, our liquidity results.
Within these measures referred to as ‘adjusted’, we adjust for significant items which will not be settled in cash, or which we believe to be items that are not core to our current or future operations. Some of these items may not be applicable for the current quarter, however they are expected to be part of our full-year results. These items include the following:
We evaluate our revenue on an as reported (U.S. GAAP), constant currency and organic basis. We believe presenting constant currency and organic information provides valuable supplemental information regarding our comparable results, consistent with how we evaluate our performance internally.
Willis Towers Watson considers Constant Currency Change, Organic Change, Adjusted Operating Income, Adjusted EBITDA, Adjusted Net Income, Adjusted Diluted Earnings Per Share, Adjusted Income Before Taxes, Adjusted Income Taxes/Rate and Free Cash Flow to be important financial measures, which are used to internally evaluate and assess our core operations and to benchmark our operating and liquidity results against our competitors. These non-GAAP measures are important in illustrating what Willis Towers Watson’s comparable operating and liquidity results would have been had the Company not incurred transaction-related and non-recurring items. Willis Towers Watson’s non-GAAP measures and their accompanying definitions are presented as follows:
Constant Currency Change – represents the year-over-year change in revenue excluding the impact of foreign currency fluctuations. To calculate this impact, the prior year local currency results are first translated using the current year monthly average exchange rates. The change is calculated by comparing the prior year revenue, translated at the current year monthly average exchange rates, to the current year as reported revenue, for the same period. We believe constant currency measures provide useful information to investors because they provide transparency to performance by excluding the effects that foreign currency exchange rate fluctuations have on period-over-period comparability given volatility in foreign currency exchange markets.
Organic Change – excludes the impact of fluctuations in foreign currency exchange rates, as described above and the period-over-period impact of acquisitions and divestitures on current-year revenue. We believe that excluding transaction-related items from our U.S. GAAP financial measures provides useful supplemental information to our investors, and it is important in illustrating what our core operating results would have been had we not included these transaction-related items, since the nature, size and number of these translation-related items can vary from period to period.
Adjusted Operating Income/Margin – Income from Operations adjusted for amortization, transaction and integration expenses and non-recurring items that, in management’s judgment, significantly affect the period-over-period assessment of operating results. Adjusted Operating Income Margin is calculated by dividing adjusted operating income by revenue.
Adjusted EBITDA/Margin – Net Income adjusted for provision for income taxes, interest expense, depreciation and amortization, transaction and integration expenses, (gain)/loss on disposal of operations and non-recurring items that, in management’s judgment, significantly affect the period-over-period assessment of operating results. Adjusted EBITDA Margin is calculated by dividing adjusted EBITDA by revenue.
Adjusted Net Income – Net Income Attributable to Willis Towers Watson adjusted for amortization, transaction and integration expenses, (gain)/loss on disposal of operations and non-recurring items that, in management’s judgment, significantly affect the period-over-period assessment of operating results, the related tax effect of those adjustments and the tax effects of internal reorganizations. This measure is used solely for the purpose of calculating adjusted diluted earnings per share.
Adjusted Diluted Earnings Per Share – Adjusted Net Income divided by the weighted-average number of shares of common stock, diluted.
Adjusted Income Before Taxes – Income from operations before income taxes adjusted for amortization, transaction and integration expenses, (gain)/loss on disposal of operations and non-recurring items that, in management’s judgment, significantly affect the period-over-period assessment of operating results. Adjusted income before taxes is used solely for the purpose of calculating the adjusted income tax rate.
Adjusted Income Taxes/Tax Rate – Provision for income taxes adjusted for taxes on certain items of amortization, transaction and integration expenses, (gain)/loss on disposal of operations, the tax effects of internal reorganizations, and non-recurring items that, in management’s judgment, significantly affect the period-over-period assessment of operating results, divided by adjusted income before taxes. Adjusted income taxes is used solely for the purpose of calculating the adjusted income tax rate.
Free Cash Flow – Cash flows from operating activities less cash used to purchase fixed assets and software for internal use. Free Cash Flow is a liquidity measure and is not meant to represent residual cash flow available for discretionary expenditures.
These non-GAAP measures are not defined in the same manner by all companies and may not be comparable to other similarly titled measures of other companies. Non-GAAP measures should be considered in addition to, and not as a substitute for, the information contained within our condensed consolidated financial statements.
Reconciliations of these measures are included in the accompanying tables with the following exception.
The Company does not reconcile its forward looking non-GAAP financial measures to the corresponding U.S. GAAP measures, due to variability and difficulty in making accurate forecasts and projections and/or certain information not being ascertainable or accessible; and because not all of the information, such as foreign currency impacts necessary for a quantitative reconciliation of these forward-looking non-GAAP financial measures to the most directly comparable U.S. GAAP financial measure, is available to the Company without unreasonable efforts. For the same reasons, the Company is unable to address the probable significance of the unavailable information. The Company provides non-GAAP financial measures that it believes will be achieved, however it cannot accurately predict all of the components of the adjusted calculations and the U.S. GAAP measures may be materially different than the non-GAAP measures.
Willis Towers Watson Forward-Looking Statements
This document contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements and other forward-looking statements in this document by words such as “may”, “will”, “would”, “expect”, “anticipate”, “believe”, “estimate”, “plan”, “intend”, “continue”, or similar words, expressions or the negative of such terms or other comparable terminology. These statements include, but are not limited to, such things as our outlook, future capital expenditures, future share repurchases, growth in revenue, the impact of changes to tax laws on our financial results, business strategies and planned acquisitions (including the acquisition of TRANZACT), competitive strengths, goals, the benefits of new initiatives, growth of our business and operations, plans and references to future successes, including our future financial and operating results, plans, objectives, expectations and intentions and other statements that are not historical facts. Such statements are based upon the current beliefs and expectations of Willis Towers Watson’s management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. All forward-looking disclosure is speculative by its nature.
There are important risks, uncertainties, events and factors that could cause our actual results or performance to differ materially from those in the forward-looking statements contained herein, including the following: the ability of the company to successfully establish, execute and achieve its global business strategy as it evolves; changes in demand for our services, including any decline in defined benefit pension plans or the purchasing of insurance; changes in general economic, business and political conditions, including changes in the financial markets; significant competition that the company faces and the potential for loss of market share and/or profitability; the impact of seasonality and differences in timing of renewals; the risk of increased liability or new legal claims arising from our new and existing products and services, and expectations, intentions and outcomes relating to outstanding litigation; the risk the Stanford litigation settlement approval will be overturned on appeal, the risk that the Stanford bar order may be challenged in other jurisdictions, and the risk that the charge related to the Stanford settlement may not be deductible; the risk of material adverse outcomes on existing litigation or investigation matters; changes in the regulatory environment in which the company operates, including, among other risks, the impact of pending competition law and regulatory investigations; various claims, government inquiries or investigations or the potential for regulatory action; the company’s ability to make divestitures or acquisitions and its ability to integrate or manage such acquired businesses (including the recently completed acquisition of TRANZACT); failure to protect client data or breaches of information systems; the ability to comply with complex and evolving regulations related to data privacy and cyber security; the potential impact of Brexit; our ability to successfully enhance our billing, collection and other working capital efforts, and thereby increase our free cash flow; the potential impact of the change in the method for determining LIBOR; the ability of the company to properly identify and manage conflicts of interest; reputational damage; reliance on third-party services; the loss of key employees; the ability to successfully manage ongoing organizational changes; disasters or business continuity problems; doing business internationally, including the impact of exchange rates; compliance with extensive government regulation; the risk of sanctions imposed by governments, or changes to associated sanction regulations; technological change; changes and developments in the insurance industry or the United States healthcare system; the risk that the company may not be able to repurchase the intended number of outstanding shares due to M&A activity or investment opportunities, market or business conditions, or other factors; the inability to protect the company’s intellectual property rights, or the potential infringement upon the intellectual property rights of others; fluctuations in the company’s pension liabilities; the ability of the company to meet its financial guidance, the company’s capital structure, including indebtedness amounts, the limitations imposed by the covenants in the documents governing such indebtedness and the maintenance of the financial and disclosure controls and procedures of each; the ability of the company to obtain financing on favorable terms or at all; adverse changes in the credit ratings of the company; the impact of recent changes to U.S. tax laws, including on our effective tax rate, and the enactment of additional, or the revision of existing, state, federal, and/or foreign regulatory and tax laws and regulations; U.S. federal income tax consequences to U.S. persons owning at least 10% of the company’s shares; changes in accounting principles, estimates or assumptions; fluctuation in revenue against the company’s relatively fixed expenses; the laws of Ireland being different from the laws of the United States and potentially affording less protections to the holders of our securities; and the company's holding company structure potentially preventing it from being able to receive dividends or other distributions in needed amounts from our subsidiaries. These factors also include those described under “Risk Factors” in the company’s most recent 10-K filing and subsequent filings filed with the SEC.
Although we believe that the assumptions underlying our forward-looking statements are reasonable, any of these assumptions, and therefore also the forward-looking statements based on these assumptions, could themselves prove to be inaccurate. In light of the significant uncertainties inherent in the forward-looking statements included in this document, our inclusion of this information is not a representation or guarantee by us that our objectives and plans will be achieved.
Our forward-looking statements speak only as of the date made and we will not update these forward-looking statements unless the securities laws require us to do so. In light of these risks, uncertainties and assumptions, the forward-looking events discussed in this document may not occur, and we caution you against relying on these forward-looking statements.
Contact
INVESTORS
Rich Keefe | +1 215 246 3961 | Rich.Keefe@willistowerswatson.com
WILLIS TOWERS WATSON
Supplemental Segment Information
(In millions of U.S. dollars)
(Unaudited)
REVENUE | |||||||||||||||||||||||||||||||||
Components of Revenue Change(i) | |||||||||||||||||||||||||||||||||
Three Months Ended June 30, | As Reported | Currency | Constant Currency | Acquisitions/ | Organic | ||||||||||||||||||||||||||||
2019 | 2018 | % Change | Impact | Change | Divestitures | Change | |||||||||||||||||||||||||||
Human Capital & Benefits | $ | 797 | $ | 780 | 2% | (3)% | 5% | 0% | 5% | ||||||||||||||||||||||||
Corporate Risk & Broking | 690 | 674 | 2% | (3)% | 5% | 0% | 5% | ||||||||||||||||||||||||||
Investment, Risk & Reinsurance | 409 | 385 | 6% | (3)% | 9% | 1% | 8% | ||||||||||||||||||||||||||
Benefits Delivery & Administration | 126 | 119 | 6% | 0% | 6% | 0% | 6% | ||||||||||||||||||||||||||
Segment Revenue | 2,022 | 1,958 | 3% | (3)% | 6% | 0% | 6% | ||||||||||||||||||||||||||
Reimbursable expenses and other | 26 | 32 | |||||||||||||||||||||||||||||||
Revenue | $ | 2,048 | $ | 1,990 | 3% | (3)% | 6% | 0% | 6% | ||||||||||||||||||||||||
Components of Revenue Change(i) | |||||||||||||||||||||||||||||||||
Six Months Ended June 30, | As Reported | Currency | Constant Currency | Acquisitions/ | Organic | ||||||||||||||||||||||||||||
2019 | 2018 | % Change | Impact | Change | Divestitures | Change | |||||||||||||||||||||||||||
Human Capital & Benefits | $ | 1,626 | $ | 1,612 | 1% | (3)% | 4% | 0% | 4% | ||||||||||||||||||||||||
Corporate Risk & Broking | 1,418 | 1,414 | 0% | (4)% | 4% | 0% | 5% | ||||||||||||||||||||||||||
Investment, Risk & Reinsurance | 998 | 959 | 4% | (3)% | 8% | 1% | 6% | ||||||||||||||||||||||||||
Benefits Delivery & Administration | 261 | 241 | 8% | 0% | 8% | 0% | 8% | ||||||||||||||||||||||||||
Segment Revenue | 4,303 | 4,226 | 2% | (3)% | 5% | 0% | 5% | ||||||||||||||||||||||||||
Reimbursable expenses and other | 57 | 56 | |||||||||||||||||||||||||||||||
Revenue | $ | 4,360 | $ | 4,282 | 2% | (3)% | 5% | 0% | 5% |
_______
(i) Components of revenue change may not add due to rounding
SEGMENT OPERATING INCOME (i)
Three Months Ended June 30, | ||||||||
2019 | 2018 | |||||||
Human Capital & Benefits | $ | 169 | $ | 149 | ||||
Corporate Risk & Broking | 104 | 97 | ||||||
Investment, Risk & Reinsurance | 109 | 89 | ||||||
Benefits Delivery & Administration | (25 | ) | (31 | ) | ||||
Segment Operating Income | $ | 357 | $ | 304 | ||||
Six Months Ended June 30, | ||||||||
2019 | 2018 | |||||||
Human Capital & Benefits | $ | 373 | $ | 342 | ||||
Corporate Risk & Broking | 231 | 222 | ||||||
Investment, Risk & Reinsurance | 361 | 350 | ||||||
Benefits Delivery & Administration | (46 | ) | (63 | ) | ||||
Segment Operating Income | $ | 919 | $ | 851 |
_______
(i) Segment operating income excludes certain costs, including amortization of intangibles, transaction and integration expenses, certain litigation provisions, and to the extent that the actual expense based upon which allocations are made differs from the forecast/budget amount, a reconciling item will be created between internally allocated expenses and the actual expenses reported for U.S. GAAP purposes.
RECONCILIATIONS OF SEGMENT OPERATING INCOME TO INCOME FROM OPERATIONS BEFORE INCOME TAXES
Three Months Ended June 30, | ||||||||
2019 | 2018 | |||||||
Segment Operating Income | $ | 357 | $ | 304 | ||||
Amortization | (123 | ) | (140 | ) | ||||
Transaction and integration expenses | — | (55 | ) | |||||
Unallocated, net(i) | (58 | ) | (46 | ) | ||||
Income from Operations | 176 | 63 | ||||||
Interest expense | (56 | ) | (52 | ) | ||||
Other income, net | 67 | 63 | ||||||
Income from operations before income taxes | $ | 187 | $ | 74 | ||||
Six Months Ended June 30, | ||||||||
2019 | 2018 | |||||||
Segment Operating Income | $ | 919 | $ | 851 | ||||
Amortization | (250 | ) | (281 | ) | ||||
Transaction and integration expenses | (6 | ) | (98 | ) | ||||
Unallocated, net(i) | (128 | ) | (150 | ) | ||||
Income from Operations | 535 | 322 | ||||||
Interest expense | (110 | ) | (103 | ) | ||||
Other income, net | 122 | 119 | ||||||
Income from operations before income taxes | $ | 547 | $ | 338 |
______
(i) Includes certain costs, primarily related to corporate functions which are not directly related to the segments, and certain differences between budgeted expenses determined at the beginning of the year and actual expenses that we report for U.S. GAAP purposes.
WILLIS TOWERS WATSON
Reconciliations of Non-GAAP Measures
(In millions of U.S. dollars, except per share data)
(Unaudited)
RECONCILIATIONS OF NET INCOME ATTRIBUTABLE TO WILLIS TOWERS WATSON TO ADJUSTED DILUTED EARNINGS PER SHARE
Three Months Ended June 30, | ||||||||
2019 | 2018 | |||||||
Net income attributable to Willis Towers Watson | $ | 138 | $ | 58 | ||||
Adjusted for certain items: | ||||||||
Amortization | 123 | 140 | ||||||
Transaction and integration expenses | — | 55 | ||||||
Pension settlement and curtailment gains and losses | — | 20 | ||||||
Tax effect on certain items listed above(i) | (29 | ) | (48 | ) | ||||
Adjusted net income | $ | 232 | $ | 225 | ||||
Weighted-average shares of common stock — diluted | 130 | 133 | ||||||
Diluted earnings per share | $ | 1.06 | $ | 0.44 | ||||
Adjusted for certain items:(ii) | ||||||||
Amortization | 0.94 | 1.06 | ||||||
Transaction and integration expenses | — | 0.41 | ||||||
Pension settlement and curtailment gains and losses | — | 0.15 | ||||||
Tax effect on certain items listed above(i) | (0.22 | ) | (0.36 | ) | ||||
Adjusted diluted earnings per share | $ | 1.78 | $ | 1.7 | ||||
Six Months Ended June 30, | ||||||||
2019 | 2018 | |||||||
Net income attributable to Willis Towers Watson | $ | 425 | $ | 273 | ||||
Adjusted for certain items: | ||||||||
Amortization | 250 | 281 | ||||||
Transaction and integration expenses | 6 | 98 | ||||||
Pension settlement and curtailment gains and losses | — | 20 | ||||||
Loss on disposal of operations | — | 9 | ||||||
Tax effect on certain items listed above(i) | (61 | ) | (95 | ) | ||||
Adjusted net income | $ | 620 | $ | 586 | ||||
Weighted-average shares of common stock — diluted | 130 | 133 | ||||||
Diluted earnings per share | $ | 3.26 | $ | 2.05 | ||||
Adjusted for certain items:(ii) | ||||||||
Amortization | 1.92 | 2.11 | ||||||
Transaction and integration expenses | 0.05 | 0.74 | ||||||
Pension settlement and curtailment gains and losses | — | 0.15 | ||||||
Loss on disposal of operations | — | 0.07 | ||||||
Tax effect on certain items listed above(i) | (0.47 | ) | (0.71 | ) | ||||
Adjusted diluted earnings per share | $ | 4.76 | $ | 4.41 |
______
(i) The tax effect was calculated using an effective tax rate for each item.
(ii) Per share values and totals may differ due to rounding.
RECONCILIATIONS OF NET INCOME TO ADJUSTED EBITDA
Three Months Ended June 30, | ||||||||||||||
2019 | 2018 | |||||||||||||
Net income | $ | 149 | 7.3 | % | $ | 65 | 3.3 | % | ||||||
Provision for income taxes | 38 | 9 | ||||||||||||
Interest expense | 56 | 52 | ||||||||||||
Depreciation | 59 | 51 | ||||||||||||
Amortization | 123 | 140 | ||||||||||||
Transaction and integration expenses | — | 55 | ||||||||||||
Pension settlement and curtailment gains and losses | — | 20 | ||||||||||||
Adjusted EBITDA and adjusted EBITDA margin | $ | 425 | 20.8 | % | $ | 392 | 19.7 | % | ||||||
Six Months Ended June 30, | ||||||||||||||
2019 | 2018 | |||||||||||||
Net income | $ | 442 | 10.1 | % | $ | 286 | 6.7 | % | ||||||
Provision for income taxes | 105 | 52 | ||||||||||||
Interest expense | 110 | 103 | ||||||||||||
Depreciation | 113 | 100 | ||||||||||||
Amortization | 250 | 281 | ||||||||||||
Transaction and integration expenses | 6 | 98 | ||||||||||||
Pension settlement and curtailment gains and losses | — | 20 | ||||||||||||
Loss on disposal of operations | — | 9 | ||||||||||||
Adjusted EBITDA and adjusted EBITDA margin | $ | 1,026 | 23.5 | % | $ | 949 | 22.2 | % | ||||||
RECONCILIATIONS OF INCOME FROM OPERATIONS TO ADJUSTED OPERATING INCOME
Three Months Ended June 30, | ||||||||||||||
2019 | 2018 | |||||||||||||
Income from operations | $ | 176 | 8.6 | % | $ | 63 | 3.2 | % | ||||||
Adjusted for certain items: | ||||||||||||||
Amortization | 123 | 140 | ||||||||||||
Transaction and integration expenses | — | 55 | ||||||||||||
Adjusted operating income and adjusted operating income margin | $ | 299 | 14.6 | % | $ | 258 | 13 | % | ||||||
Six Months Ended June 30, | ||||||||||||||
2019 | 2018 | |||||||||||||
Income from operations | $ | 535 | 12.3 | % | $ | 322 | 7.5 | % | ||||||
Adjusted for certain items: | ||||||||||||||
Amortization | 250 | 281 | ||||||||||||
Transaction and integration expenses | 6 | 98 | ||||||||||||
Adjusted operating income and adjusted operating income margin | $ | 791 | 18.1 | % | $ | 701 | 16.4 | % | ||||||
RECONCILIATIONS OF GAAP INCOME TAXES/TAX RATE TO ADJUSTED INCOME TAXES/TAX RATE
Three Months Ended June 30, | ||||||||
2019 | 2018 | |||||||
Income from operations before income taxes | $ | 187 | $ | 74 | ||||
Adjusted for certain items: | ||||||||
Amortization | 123 | 140 | ||||||
Transaction and integration expenses | — | 55 | ||||||
Pension settlement and curtailment gains and losses | — | 20 | ||||||
Adjusted income before taxes | $ | 310 | $ | 289 | ||||
Provision for income taxes | $ | 38 | $ | 9 | ||||
Tax effect on certain items listed above(i) | 29 | 48 | ||||||
Adjusted income taxes | $ | 67 | $ | 57 | ||||
U.S. GAAP tax rate | 19.7 | % | 12.7 | % | ||||
Adjusted income tax rate | 21.4 | % | 19.7 | % | ||||
Six Months Ended June 30, | ||||||||
2019 | 2018 | |||||||
Income from operations before income taxes | $ | 547 | $ | 338 | ||||
Adjusted for certain items: | ||||||||
Amortization | 250 | 281 | ||||||
Transaction and integration expenses | 6 | 98 | ||||||
Pension settlement and curtailment gains and losses | — | 20 | ||||||
Loss on disposal of operations | — | 9 | ||||||
Adjusted income before taxes | $ | 803 | $ | 746 | ||||
Provision for income taxes | $ | 105 | $ | 52 | ||||
Tax effect on certain items listed above(i) | 61 | 95 | ||||||
Adjusted income taxes | $ | 166 | $ | 147 | ||||
U.S. GAAP tax rate | 19.1 | % | 15.5 | % | ||||
Adjusted income tax rate | 20.6 | % | 19.7 | % |
______
(i) The tax effect was calculated using an effective tax rate for each item.
RECONCILIATION OF CASH FLOWS FROM OPERATING ACTIVITIES TO FREE CASH FLOW
Six Months Ended June 30, | ||||||||
2019 | 2018 | |||||||
Cash flows from operating activities | $ | 303 | $ | 395 | ||||
Less: Additions to fixed assets and software for internal use | (120 | ) | (141 | ) | ||||
Free cash flow | $ | 183 | $ | 254 | ||||
WILLIS TOWERS WATSON
Condensed Consolidated Statements of Income
(In millions of U.S. dollars, except per share data)
(Unaudited)
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2019 | 2018 | 2019 | 2018 | |||||||||||||
Revenue | $ | 2,048 | $ | 1,990 | $ | 4,360 | $ | 4,282 | ||||||||
Costs of providing services | ||||||||||||||||
Salaries and benefits | 1,278 | 1,275 | 2,626 | 2,652 | ||||||||||||
Other operating expenses | 412 | 406 | 830 | 829 | ||||||||||||
Depreciation | 59 | 51 | 113 | 100 | ||||||||||||
Amortization | 123 | 140 | 250 | 281 | ||||||||||||
Transaction and integration expenses | — | 55 | 6 | 98 | ||||||||||||
Total costs of providing services | 1,872 | 1,927 | 3,825 | 3,960 | ||||||||||||
Income from operations | 176 | 63 | 535 | 322 | ||||||||||||
Interest expense | (56 | ) | (52 | ) | (110 | ) | (103 | ) | ||||||||
Other income, net | 67 | 63 | 122 | 119 | ||||||||||||
INCOME FROM OPERATIONS BEFORE INCOME TAXES | 187 | 74 | 547 | 338 | ||||||||||||
Provision for income taxes | (38 | ) | (9 | ) | (105 | ) | (52 | ) | ||||||||
NET INCOME | 149 | 65 | 442 | 286 | ||||||||||||
Income attributable to non-controlling interests | (11 | ) | (7 | ) | (17 | ) | (13 | ) | ||||||||
NET INCOME ATTRIBUTABLE TO WILLIS TOWERS WATSON | $ | 138 | $ | 58 | $ | 425 | $ | 273 | ||||||||
EARNINGS PER SHARE | ||||||||||||||||
Basic earnings per share | $ | 1.06 | $ | 0.44 | $ | 3.27 | $ | 2.06 | ||||||||
Diluted earnings per share | $ | 1.06 | $ | 0.44 | $ | 3.26 | $ | 2.05 | ||||||||
Weighted-average shares of common stock, basic | 130 | 132 | 130 | 132 | ||||||||||||
Weighted-average shares of common stock, diluted | 130 | 133 | 130 | 133 | ||||||||||||
WILLIS TOWERS WATSON
Condensed Consolidated Balance Sheets
(In millions of U.S. dollars, except share data)
(Unaudited)
June 30, | December 31, | |||||||
2019 | 2018 | |||||||
ASSETS | ||||||||
Cash and cash equivalents | $ | 812 | $ | 1,033 | ||||
Fiduciary assets | 14,609 | 12,604 | ||||||
Accounts receivable, net | 2,461 | 2,379 | ||||||
Prepaid and other current assets | 451 | 404 | ||||||
Total current assets | 18,333 | 16,420 | ||||||
Fixed assets, net | 967 | 942 | ||||||
Goodwill | 10,454 | 10,465 | ||||||
Other intangible assets, net | 3,055 | 3,318 | ||||||
Right-of-use assets | 930 | — | ||||||
Pension benefits assets | 886 | 773 | ||||||
Other non-current assets | 541 | 467 | ||||||
Total non-current assets | 16,833 | 15,965 | ||||||
TOTAL ASSETS | $ | 35,166 | $ | 32,385 | ||||
LIABILITIES AND EQUITY | ||||||||
Fiduciary liabilities | $ | 14,609 | $ | 12,604 | ||||
Deferred revenue and accrued expenses | 1,444 | 1,647 | ||||||
Current debt | 187 | 186 | ||||||
Current lease liabilities | 154 | — | ||||||
Other current liabilities | 810 | 864 | ||||||
Total current liabilities | 17,204 | 15,301 | ||||||
Long-term debt | 4,284 | 4,389 | ||||||
Liability for pension benefits | 1,125 | 1,170 | ||||||
Deferred tax liabilities | 532 | 559 | ||||||
Provision for liabilities | 549 | 540 | ||||||
Long-term lease liabilities | 941 | — | ||||||
Other non-current liabilities | 299 | 429 | ||||||
Total non-current liabilities | 7,730 | 7,087 | ||||||
TOTAL LIABILITIES | 24,934 | 22,388 | ||||||
COMMITMENTS AND CONTINGENCIES | ||||||||
REDEEMABLE NON-CONTROLLING INTEREST | 28 | 26 | ||||||
EQUITY(i) | ||||||||
Additional paid-in capital | 10,644 | 10,615 | ||||||
Retained earnings | 1,442 | 1,201 | ||||||
Accumulated other comprehensive loss, net of tax | (1,993 | ) | (1,961 | ) | ||||
Treasury shares, at cost, 17,519 shares in 2019 and 2018, and 40,000 shares, €1 nominal value, in 2019 and 2018 | (3 | ) | (3 | ) | ||||
Total Willis Towers Watson shareholders' equity | 10,090 | 9,852 | ||||||
Non-controlling interests | 114 | 119 | ||||||
Total Equity | 10,204 | 9,971 | ||||||
TOTAL LIABILITIES AND EQUITY | $ | 35,166 | $ | 32,385 | ||||
(i) Equity includes (a) Ordinary shares $0.000304635 nominal value; Authorized 1,510,003,775; Issued 128,982,802 (2019) and 128,921,530 (2018); Outstanding 128,982,802 (2019) and 128,921,530 (2018); (b) Ordinary shares, €1 nominal value; Authorized and Issued 40,000 shares in 2019 and 2018; and (c) Preference shares, $0.000115 nominal value; Authorized 1,000,000,000 and Issued none in 2019 and 2018.
WILLIS TOWERS WATSON
Condensed Consolidated Statements of Cash Flows
(In millions of U.S. dollars)
(Unaudited)
Six Months Ended June 30, | ||||||||
2019 | 2018 | |||||||
CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
NET INCOME | $ | 442 | $ | 286 | ||||
Adjustments to reconcile net income to total net cash from operating activities: | ||||||||
Depreciation | 113 | 104 | ||||||
Amortization | 250 | 281 | ||||||
Non-cash lease expense | 72 | — | ||||||
Net periodic benefit of defined benefit pension plans | (64 | ) | (78 | ) | ||||
Provision for doubtful receivables from clients | 10 | 10 | ||||||
Benefit from deferred income taxes | (41 | ) | (48 | ) | ||||
Share-based compensation | 27 | 4 | ||||||
Net loss on disposal of operations | — | 9 | ||||||
Non-cash foreign exchange loss | 13 | 15 | ||||||
Other, net | (6 | ) | 3 | |||||
Changes in operating assets and liabilities, net of effects from purchase of subsidiaries: | ||||||||
Accounts receivable | (82 | ) | 81 | |||||
Fiduciary assets | (1,961 | ) | (2,193 | ) | ||||
Fiduciary liabilities | 1,961 | 2,193 | ||||||
Other assets | (164 | ) | 70 | |||||
Other liabilities | (285 | ) | (325 | ) | ||||
Provisions | 18 | (17 | ) | |||||
Net cash from operating activities | 303 | 395 | ||||||
CASH FLOWS USED IN INVESTING ACTIVITIES | ||||||||
Additions to fixed assets and software for internal use | (120 | ) | (141 | ) | ||||
Capitalized software costs | (34 | ) | (25 | ) | ||||
Acquisitions of operations, net of cash acquired | (1 | ) | (8 | ) | ||||
Net proceeds from sale of operations | 13 | 4 | ||||||
Other, net | (6 | ) | 17 | |||||
Net cash used in investing activities | (148 | ) | (153 | ) | ||||
CASH FLOWS USED IN FINANCING ACTIVITIES | ||||||||
Net (repayments)/borrowings on revolving credit facility | (106 | ) | 197 | |||||
Repayments of debt | (3 | ) | (43 | ) | ||||
Repurchase of shares | (51 | ) | (269 | ) | ||||
Proceeds from issuance of shares | 27 | 18 | ||||||
Payments of deferred and contingent consideration related to acquisitions | (47 | ) | (41 | ) | ||||
Cash paid for employee taxes on withholding shares | (12 | ) | (30 | ) | ||||
Dividends paid | (161 | ) | (149 | ) | ||||
Acquisitions of and dividends paid to non-controlling interests | (21 | ) | (18 | ) | ||||
Net cash used in financing activities | (374 | ) | (335 | ) | ||||
DECREASE IN CASH AND CASH EQUIVALENTS | (219 | ) | (93 | ) | ||||
Effect of exchange rate changes on cash and cash equivalents | (2 | ) | (26 | ) | ||||
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD | 1,033 | 1,030 | ||||||
CASH AND CASH EQUIVALENTS, END OF PERIOD | $ | 812 | $ | 911 | ||||
EXHIBIT 99.2
willisto w e r s wat s o n .c o m Willis Towers Watson 2019 Second Quarter Financial Results Supplemental Materials July 31, 2019 © 2019 Willis Towers Watson. All rights reserved.
Willis Towers Watson Forward Looking Statements willistowerswatson.com © 2019 Willis Towers Watson. All rights reserved. 1 This document contains “forward - looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements and other forward - looking statements in this document by words such as “may”, “will”, “would”, “expect”, “anticipate”, “believe”, “estimate”, “plan”, “intend”, “continue”, or similar words, expressions or the negative of such terms or other comparable terminology. These statements include, but are not limited to, such things as our outlook, future capital expenditures, future share repurchases, growth in revenue, the impact of changes to tax laws on our financial results, business strategies and planned acquisitions (including the acquisition of TRANZACT), competitive strengths, goals, the benefits of new initiatives, growth of our business and operations, plans and references to future successes, including our future financial and operating results, plans, objectives, expectations and intentions and other statements that are not historical facts. Such statements are based upon the current beliefs and expectations of Willis Towers Watson’s management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward - looking statements. All forward - looking disclosure is speculative by its nature. There are important risks, uncertainties, events and factors that could cause our actual results or performance to differ materially from those in the forward - looking statements contained herein, including the following: the ability of the company to successfully establish, execute and achieve its global business strategy as it evolves; changes in demand for our services, including any decline in defined benefit pension plans or the purchasing of insurance; changes in general economic, business and political conditions, including changes in the financial markets; significant competition that the company faces and the potential for loss of market share and/or profitability; the impact of seasonality and differences in timing of renewals; the risk of increased liability or new legal claims arising from our new and existing products and services, and expectations, intentions and outcomes relating to outstanding litigation; the risk the Stanford litigation settlement approval will be overturned on appeal, the risk that the Stanford bar order may be challenged in other jurisdictions, and the risk that the charge related to the Stanford settlement may not be deductible; the risk of material adverse outcomes on existing litigation or investigation matters; changes in the regulatory environment in which the company operates, including, among other risks, the impact of pending competition law and regulatory investigations; various claims, government inquiries or investigations or the potential for regulatory action; the company’s ability to make divestitures or acquisitions and its ability to integrate or manage such acquired businesses (including the recently completed acquisition of TRANZACT); failure to protect client data or breaches of information systems; the ability to comply with complex and evolving regulations related to data privacy and cyber security; the potential impact of Brexit; our ability to successfully enhance our billing, collection and other working capital efforts, and thereby increase our free cash flow; the potential impact of the change in the method for determining LIBOR; the ability of the company to properly identify and manage conflicts of interest; reputational damage; reliance on third - party services; the loss of key employees; the ability to successfully manage ongoing organizational changes; disasters or business continuity problems; doing business internationally, including the impact of exchange rates; compliance with extensive government regulation; the risk of sanctions imposed by governments, or changes to associated sanction regulations; technological change; changes and developments in the insurance industry or the United States healthcare system; the risk that the company may not be able to repurchase the intended number of outstanding shares due to M&A activity or investment opportunities, market or business conditions, or other factors; the inability to protect the company’s intellectual property rights, or the potential infringement upon the intellectual property rights of others; fluctuations in the company’s pension liabilities; the ability of the company to meet its financial guidance, the company’s capital structure, including indebtedness amounts, the limitations imposed by the covenants in the documents governing such indebtedness and the maintenance of the financial and disclosure controls and procedures of each; the ability of the company to obtain financing on favorable terms or at all; adverse changes in the credit ratings of the company; the impact of recent changes to U.S. tax laws, including on our effective tax rate, and the enactment of additional, or the revision of existing, state, federal, and/or foreign regulatory and tax laws and regulations; U.S. federal income tax consequences to U.S. persons owning at least 10% of the company’s shares; changes in accounting principles, estimates or assumptions; fluctuation in revenue against the company’s relatively fixed expenses; the laws of Ireland being different from the laws of the United States and potentially affording less protections to the holders of our securities; and the company's holding company structure potentially preventing it from being able to receive dividends or other distributions in needed amounts from our subsidiaries. These factors also include those described under “Risk Factors” in the company’s most recent 10 - K filing and subsequent filings filed with the SEC.
Willis Towers Watson Non - GAAP Measures willistowerswatson.com © 2019 Willis Towers Watson. All rights reserved. 2 In order to assist readers of our consolidated financial statements in understanding the core operating results that Willis Towers Watson’s management uses to evaluate the business and for financial planning, we present the following non - GAAP measures: (1) Constant Currency Change, (2) Organic Change, (3) Adjusted Operating Income, (4) Adjusted EBITDA, (5) Adjusted Net Income, (6) Adjusted Diluted Earnings Per Share, (7) Adjusted Income Before Taxes, (8) Adjusted Income Taxes/Tax Rate and (9) Free Cash Flow. The Company believes that these measures are relevant and provide useful information widely used by analysts, investors and other interested parties in our industry to provide a baseline for evaluating and comparing our operating performance, and in the case of free cash flow, our liquidity results. Reconciliations of these measures are included in the accompanying appendix of these earning release supplemental materials. The Company does not reconcile its forward looking non - GAAP financial measures to the corresponding U.S. GAAP measures, due to variability and difficulty in making accurate forecasts and projections and/or certain information not being ascertainable or accessible; and because not all of the information, such as foreign currency impacts necessary for a quantitative reconciliation of these forward - looking non - GAAP financial measures to the most directly comparable U.S. GAAP financial measure, is available to the Company without unreasonable efforts. For the same reasons, the Company is unable to address the probable significance of the unavailable information. The Company provides non - GAAP financial measures that it believes will be achieved, however it cannot accurately predict all of the components of the adjusted calculations and the U.S. GAAP measures may be materially different than the non - GAAP measures.
Q2 2019 GAAP Financial Results, Key Figures willistowerswatson.com © 2019 Willis Towers Watson. All rights reserved. 3 $USD million, except EPS and % Three months ending June, Six months ending June, 2018 2019 2018 2019 Revenue as reported % change $1,990 $2,048 +3% $4,282 $4,360 +2% Income from Operations as reported % change $63 $176 +179% $322 $535 +66% Operating Margin % as reported change, basis points 3.2% 8.6% +540 bps 7.5% 12.3% +480 bps Net Income attributable to Willis Towers Watson as reported % change $58 $138 +138% $273 $425 +56% Diluted EPS as reported % change $0.44 $1.06 +141% $2.05 $3.26 +59% Operating Cash Flow as reported % change $395 $303 - 23%
$ 2.0 B Q2 2019 Revenue Q2 2019 Key Figures, Includes Non - GAAP Financial Results Willis Towers Watson reports strong results for Q2 2019 Total Revenue + 6 % Q2 2019 Organic % Strong Growth Momentum Achieved another strong quarter with 6% organic revenue growth after 6% organic revenue growth in Q1 2019 driven by new business wins and client retention Delivering a client winning experience across 140 countries with the combined strength of Willis Towers Watson $ 18 3 M Free Cash Flow for Six Months Ended June 30, 2019 Free Cash Flow - $ 71 M YTD 2019 vs. YTD 2018 Solid Cash Generation Free cash flow was solid for the first half of 2019, and our focus continues to be on improving working capital management and thereby free cash flow generation for the remainder of 2019 $ 1.78 Q2 2019 Adj. Diluted EPS Adj. Diluted EPS Maintained Solid Growth Despite Headwind Delivered solid earnings growth of approximately 5% despite modest year - over - year headwinds related to long - term incentive compensation, foreign currency, pension income, and income taxes 14.6 % Q2 2019 Adj. Operating Margin Adj. Operating Margin Robust Margin Expansion Strong organic growth coupled with disciplined expense management is driving core margin expansion despite modest headwind from long - term incentive compensation On track to deliver 2019 adjusted operating margin of around 20% + 5 % Q2 2019 $ 1.70 Q2 2018 + 160 bps Q2 2019 13. 0 % Q2 2018 + 3 % Q2 2018 Organic % $ 254 M YTD 2018 willistowerswatson.com © 2019 Willis Towers Watson. All rights reserved. 4
Organic Revenue Growth %* willistowerswatson.com © 2019 Willis Towers Watson. All rights reserved. 5 Broad - Based Organic Growth Across All Segments Our unwavering focus to deliver a client winning experience to drive growth Q2 2018 Q2 2019 Human Capital & Benefits 3% 5% Corporate Risk & Broking 2% 5% Investment, Risk & Reinsurance 1% 8% Benefits Delivery & Administration 9% 6% Willis Towers Watson 3% 6% HCB organic revenue growth was led by Health and Benefits driven by growth in specialty products and new local and global appointments. Other Businesses in HCB experienced modest growth, and Retirement experienced a slight decline as a result of non - recurring work in the comparable period. CRB delivered solid organic revenue growth across all geographies led by North America . New business wins and high client retention continues to drive core organic growth for the CRB Segment . IRR posted strong organic revenue growth across all Businesses, including Wholesale and Investment, which rebounded nicely in Q2. The growth was driven by favorable renewal factors, client retention, and strong new business wins. BDA delivered strong organic growth driven by the continued expansion of its client base with predictable recurring revenue and increased demand for project work. • Organic revenue growth for 2018 compared to 2017 excludes the impact of ASC 606 from both years. Organic revenue growth for 2019 compared to 2018 includes the adoption of ASC 606 for both years
Summary of Segment Financial Results Q2 2019 Segment results compared to Q2 2018 willistowerswatson.com © 2019 Willis Towers Watson. All rights reserved. 6 As reported, $USD million, except % Q2 2018 Q2 2019 Revenue O p erating Margin % Revenue Operating Margin % Margin Year - over - year Human Capital & Benefits 780 19% 797 21% +200 bps Corporate Risk & Broking 674 14% 690 15% +100 bps Investment, Risk & Reinsurance 385 23% 409 27% +350 bps Benefits Delivery & Administration 119 - 26% 126 - 20% +570 bps • Revenue and Operating Margin with the adoption of ASC 606 accounting standards for both 2018 and 2019. The Operating Margin percentage is rounded
Maintaining a Strong and Flexible Balance Sheet Position Significant financial flexibility to drive long - term shareholder value willistowerswatson.com © 2019 Willis Towers Watson. All rights reserved. 7 $USD million Dec 31, 2018 June 30, 2019 June 30, 2018 Cash and Cash Equivalents 911 1,033 812 Total Debt 1 4,674 4,575 4,471 Total Equity 10,347 9,971 10,204 Debt to Adj. EBITDA TTM basis n/a 2 2.3x 2.1x A disciplined capital management strategy provides Willis Towers Watson with ample financial flexibility to reinvest in our Businesses, capitalize on market growth opportunities, and drive significant value for shareholders Our capital structure enabled by robust cash generation and a strong balance sheet paves the way for significant shareholder value creation over the long - term History of effectively managing our leverage with the commitment to maintain investment grade credit rating and return leverage ratio to historical level after the acquisition of TRANZACT 1 Total Debt equals sum of current debt and long - term debt as shown on the Consolidated Balance Sheets 2 Q2 2018 Debt to trailing twelve months Adj. EBITDA has been excluded due to 1/1/18 cutover adoption of ASC 606 revenue accounting standards
A Capital Strategy Fit For Creating Long - Term Shareholder Value CASH RETURNED TO SHAREHOLDERS $ 2.7 B FY2016 to Q2 FY2019 $396 $602 $709 $199 $595 $277 $306 $986 $908 In progress $212 $51 $161 2016 2017 2018 2019 YTD SUSTAINABLE DIVIDEND GROWTH + 11 % Cash dividend growth 3 years CAGR 2016 $0.65 $0 . 6 0 $ 0 . 4 8 2017 2018 2019 e $0 . 5 3 Share repurchases Dividends Quarterly cash dividend per share + 1 1% willistowerswatson.com © 2019 Willis Towers Watson. All rights reserved. 8 $ million Disciplined approach to capital allocation A capital light business model and capital structure allow us to shift capital between growth and value creation based on changes in the Businesses and/or the macro environment A strong focus on return on investment to optimize the use of cash A robust pipeline of investment opportunities Focus areas to prioritize use of cash 1) Reinvesting in our Businesses 2) Investing in innovation and new business opportunities 3) Opportunistic mergers, acquisitions, and divestitures 4) Enhance Balance Sheet and strengthen liquidity 5) Return excess cash to shareholders through share repurchase 6) Sustain dividends and payout ratio
Willis Towers Watson Successfully Completed the Acquisition of TRANZACT Purchase willistowerswatson.com © 2019 Willis Towers Watson. All rights reserved. 9 Price $1.3 B Total Purchase Price ▪ $1,317.5 million of total cash consideration ▪ Approximately $17 million of potential earnout payable by 2021 if certain financial targets are achieved Financing Credit Rating: Expect No Change ▪ Expect Baa3 and BBB credit rating from Moody’s and S&P, respectively. Stable outlook ▪ Secured term loan from Bank of America Merrill Lynch Governance Robust Growth Strategy & Integration Roadmap ▪ CD&R (Clayton, Dubilier & Rice) will advise on integration and help the management team maintain growth momentum ▪ TRANZACT CEO and other senior management to remain with company WTW Earnings Immediate and Meaningful Accretion Expected ▪ TRANZACT is expected to be meaningfully accretive on an adjusted EPS basis, excluding one - time transaction and integration cost of approximately $20 to $25 million A C QUIS I TION OF TRANZACT Rapidly accelerates Willis Towers Watson’s direct - to - consumer U.S. healthcare strategy Strengthens Willis Towers Watson’s position as the leader in the growing Medicare market space Delivers the next generation of benefits and healthcare technology to consumers
7 % to 8 % constant currency 4 % to 5 % organic revenue growth FY2019 Revenue Growth around 20 % Adj. operating margin FY2019 Adjusted Operating Margin $ 10.75 to $ 11.10 Adj. diluted EPS excluding $20 million to $25 million of transaction and integration cost FY2019 Adjusted Diluted EPS around 22 % Adj. income tax rate Excluding discrete items FY2019 Adjusted Income Tax Rate Annual growth of 15 % or greater (over the next 3 years) Free Cash Flow Around $0.15 currency headwind on Adj. EPS Assumes average rates £1.00 = $1.28, €1.00 = $1.13 FY2019 Foreign Currency Assumptions *Guidance is for 2019, except where specified otherwise and is based on ASC 606 accounting standard willistowerswatson.com © 2019 Willis Towers Watson. All rights reserved. 10 History of Delivering on Results. A Solid Foundation for 2019* Q2 2019 management guidance update
Appendix: Reconciliation of Non - GAAP Measures willisto w e r s wat s o n .c o m willistowerswatson.com © 2019 Willis Towers Watson. All rights reserved. Proprietary and Confidential. For Willis Towers Watson and Willis Towers Watson client use only. 11
Appendix 1: Constant currency and organic revenue change willistowerswatson.com © 2019 Willis Towers Watson. All rights reserved. 12 Components of Revenue Change (i) Three Months Ended June 30, As Reported Currency Constant Currency Acquisitions/ Organic 2019 2018 % Change Impact Change Divestitures Change Human Capital & Benefits $ 797 $ 780 2% (3)% 5% 0% 5% Corporate Risk & Broking 69 0 674 2% (3)% 5% 0% 5% Investment, Risk & Reinsurance 40 9 385 6% (3)% 9% 1% 8% Benefits Delivery & Administration 126 119 6% 0% 6% 0% 6% Segment Revenue 2,022 1,958 3% (3)% 6% 0% 6% Reimbursable expenses and other 26 32 Revenue $ 2,048 $ 1,990 3% (3)% 6% 0% 6% Components of Revenue Change (i) Six Months Ended June 30, As Reported Currency Constant Currency Acquisitions/ Organic 2019 2018 % Change Impact Change Divestitures Change Human Capital & Benefits $ 1,626 $ 1,612 1% (3)% 4% 0% 4% Corporate Risk & Broking 1 , 41 8 1 , 41 4 0% (4)% 4% 0% 5% Investment, Risk & Reinsurance 998 959 4% (3)% 8% 1% 6% Benefits Delivery & Administration 261 241 8% 0% 8% 0% 8% Segment Revenue 4,303 4 , 22 6 2% (3)% 5% 0% 5% Reimbursable expenses and other 57 56 Revenue $ 4,360 $ 4,282 2% (3)% 5% 0% 5%
Appendix 2: Adjusted operating income and margin, adjusted EBITDA and margin, free cash flow Cash flows from operating activities $ 303 $ 395 L e ss : A dd i t i on s t o f i x e d a ss e t s a n d s o f t w a r e f o r i nt e r n a l u s e ( 120 ) ( 141 ) Free Cash Flow $ 183 $ 254 Six Months Ended June 30, 2019 2018 Income from operations $ 176 8.6% $ 63 3.2% willistowerswatson.com © 2019 Willis Towers Watson. All rights reserved. 13 Adjusted for certain items: Amortization 123 140 Transaction and integration expenses — 55 Adjusted operating income $ 299 14.6% $ 258 13.0% Three Months Ended June 30, 2019 2018 Income from operations $ 535 12.3% $ 322 7 . 5 % Adjusted for certain items: Amortization 250 281 Transaction and integration expenses 6 9 8 Adjusted operating income $ 79 1 18.1% $ 701 16 . 4 % Six Months Ended June 30, 2019 2018 Three Months Ended June 30, 2019 2018 Net Income $ 149 7.3% $ 65 3 . 3 % Provision for income taxes 38 9 Interest expense 56 52 Depreciation 59 51 Amortization 123 140 Transaction and integration expenses — 55 Pension settlement and curtailment gains and losses — 2 0 Adjusted EBITDA and Adjusted EBITDA Margin $ 42 5 20 . 8 % $ 39 2 19 . 7 % Six Months Ended June 30, 2019 2018 Net Income $ 442 10.1% $ 286 6 . 7 % Provision for income taxes 105 52 Interest expense 110 103 Depreciation 113 100 Amortization 250 281 Transaction and integration expenses 6 98 Pension settlement and curtailment gains and losses — 20 Loss on disposal of operations — 9 Adjusted EBITDA and Adjusted EBITDA Margin $ 1 , 02 6 23.5% $ 949 22 . 2 %
Appendix 3: Adjusted net income, adjusted diluted earnings per share, adjusted income before taxes, adjusted income tax rate Net Income attributable to Willis Towers Watson $ 425 $ 273 Adjusted for certain items: Amortization 250 281 Transaction and integration expenses 6 98 Pension settlement and curtailment gains and losses — 20 Loss on disposal of operations — 9 T a x e ff ec t o n ce r t a i n i t e m s li s t e d a bov e ( i ) ( 61 ) ( 95 ) Adjusted Net Income $ 620 Weighted - average shares of common stock — diluted 130 Diluted Earnings Per Share $ 3.26 $ 586 133 $ 2 . 0 5 Adjusted for certain items: (ii) Amortization 1 . 9 2 2 . 1 1 Transaction and integration expenses 0 . 0 5 0 . 7 4 Pension settlement and curtailment gains and losses — 0 . 1 5 Loss on disposal of operations — 0 . 0 7 Taxeffect on certain items listed above (i) (0.47) ( 0 . 71 ) Adjusted Diluted Earnings Per Share $ 4 . 7 6 $ 4 . 4 1 Six Months Ended June 30, 2019 2018 Income from operations before income taxes $ 547 $ 338 Adjusted for certain items: Amortization 250 281 Transaction and integration expenses 6 98 Pension settlement and curtailment gains and losses — 20 Loss on disposal of operations — Adjusted income before taxes 9 $ 746 Provision for income taxes Taxeffect on certain items listed above (i) $ 803 $ 105 61 Adjusted income taxes $ 166 U.S. GAAP tax rate 19 . 1 % $ 52 95 $ 147 15.5% Adjusted income tax rate 20 . 6 % 19 . 7 % Six Months Ended June 30, 2019 2018 Three Months Ended June 30, Three Months Ended June 30, 2019 201 8 2019 201 8 Income from operations before income taxes $ 187 $ 74 Net Income attributable to Willis Towers Watson $ 138 $ 58 Adjusted for certain items: Adjusted for certain items: Amortization 123 140 Amortization 123 140 Transaction and integration expenses — 55 Transaction and integration expenses — 55 Pension settlement and curtailment gains and losses — 20 Pension settlement and curtailment gains and losses — 2 0 Taxeffect on certain items listed above (i) (29) ( 48 ) Adjusted income before taxes $ 310 $ 289 Adjusted Net Income $ 232 $ 225 Provision for income taxes $ 38 $ 9 Weighted - average shares of common stock — diluted 130 133 Taxeffect on certain items listed above (i) 29 4 8 Adjusted income taxes $ 67 $ 57 Diluted Earnings Per Share $ 1.06 $ 0.44 Adjusted for certain items: (ii) U.S. GAAP tax rate 19.7% 12 . 7 % Amortization 0 . 9 4 1 . 0 6 Adjusted income tax rate 21.4% 19 . 7 % Transaction and integration expenses — 0 . 4 1 Pension settlement and curtailment gains and losses — 0 . 1 5 Taxeffect on certain items listed above (i) (0.22) (0.36) Adjusted Diluted Earnings Per Share $ 1.78 $ 1.70 willistowerswatson.com © 2019 Willis Towers Watson. All rights reserved. 14
willistowerswatson.com About Willis Towers Watson Willis Towers Watson (NASDAQ: WLTW) is a leading global advisory, broking and solutions company that helps clients around the world turn risk into a path for growth. With roots dating to 1828, Willis Towers Watson has over 43,000 employees serving more than 140 countries. We design and deliver solutions that manage risk, optimize benefits, cultivate talent, and expand the power of capital to protect and strengthen institutions and individuals. Our unique perspective allows us to see the critical intersections between talent, assets and ideas — the dynamic formula that drives business performance. Together, we unlock potential. Learn more at willistowerswatson.com. © 2019 Willis Towers Watson. All rights reserved.